LY-2940094
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LY-2940094, covering 2025-09-25 to 2025-09-25. Get the full timeline:
Most recent: Clinical Trial Update: Investigating the Protective Impact of LY-2940094 on Stress-induced Depression- and Anxiety-related Phenotypes in Humans [Phase 2]